Baseline research biomarkers in patients with and without PA
| Biomarkers∗ . | No PA . | PA . | P value . | ||
|---|---|---|---|---|---|
| N . | Median (Q1, Q3) . | N . | Median (Q1, Q3) . | ||
| Urinary AGT (ng/mg) | 77 | 5.1 (3.46, 7.85) | 38 | 8.82 (6.08, 28.3) | <.0001 |
| Soluble VACM-1 (ng/mL) | 99 | 978.9 (807.7, 1261.4) | 55 | 1196.1 (961.3, 1565.8) | .001 |
| Urinary KIM-1 (ng/mg) | 67 | 0.50 (0.36, 0.77) | 45 | 0.85 (0.56, 1.21) | <.0001 |
| Urinary nephrin (ng/mg) | 70 | 27.7 (21.1, 35.5) | 33 | 32.4 (24.7, 40.4) | .058 |
| Biomarkers∗ . | No PA . | PA . | P value . | ||
|---|---|---|---|---|---|
| N . | Median (Q1, Q3) . | N . | Median (Q1, Q3) . | ||
| Urinary AGT (ng/mg) | 77 | 5.1 (3.46, 7.85) | 38 | 8.82 (6.08, 28.3) | <.0001 |
| Soluble VACM-1 (ng/mL) | 99 | 978.9 (807.7, 1261.4) | 55 | 1196.1 (961.3, 1565.8) | .001 |
| Urinary KIM-1 (ng/mg) | 67 | 0.50 (0.36, 0.77) | 45 | 0.85 (0.56, 1.21) | <.0001 |
| Urinary nephrin (ng/mg) | 70 | 27.7 (21.1, 35.5) | 33 | 32.4 (24.7, 40.4) | .058 |
P values are calculated from χ2 tests or Fisher exact tests if expected cell counts were small for comparing categorical characteristics and Wilcoxon-Mann-Whitney tests for comparing continuous characteristics across strata.
Urine biomarkers (AGT, KIM-1, and nephrin) were normalized for urine creatinine.